Ebola is a deadly hemorrhagic disease caused by a virus that is endemic in parts of East-Central and West Africa. Most people ...

FibroBiologics, Inc. ( (FBLG) ) has issued an announcement.

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Yorkville agreed to advance to FibroBiologics the first $15 million available under the SEPA in three equal tranches to be evidenced by convertible promissory notes. The first tranche in the amount of ...

Ebola is a deadly hemorrhagic disease caused by a virus that is endemic in parts of East-Central and West Africa. Most people are aware that a primary route for person-to-person transmission is ...

A groundbreaking study has unveiled how the Ebola virus can traverse through layers of human skin, potentially facilitating direct transmission through touch. This highlights critical cellular targets ...

Researchers at Korea University have achieved a significant breakthrough in regenerative medicine. They have demonstrated how fibroblast growth factor 4 and Ascorbic acid, known as vitamin C, can ...

A research team has unveiled an innovative technique to convert fibroblasts-common connective tissue cells-into mature and functional induced cardiomyocytes (iCMs). Their method relies on ...

OMTX-705 is under clinical development by Oncomatryx Biopharma and currently in Phase I for Non-Small Cell Lung Cancer.

Lithocholic acid (LCA), a metabolite induced by calorie restriction (CR), activates AMPK and mimics anti-aging benefits. A ...